Topics

Role of Ablative Radiotherapy in the Management of Metastatic Disease: A Prospective Patient Data Registry

2019-09-16 03:26:49 | BioPortfolio

Summary

The purpose of this study is to provide a registry of participants in order to assess the acute adverse event rates following ablative radiotherapy for metastatic disease.

Study Design

Conditions

Oligometastasis

Location

Duke University Medical Center
Durham
North Carolina
United States
27710

Status

Recruiting

Source

Duke University

Results (where available)

View Results

Links

Published on BioPortfolio: 2019-09-16T03:26:49-0400

Clinical Trials [9 Associated Clinical Trials listed on BioPortfolio]

Clinical Study of Apatinib Combined With SBRT Therapy in the Treatment of Oligometastasis of Breast Cancer

The treatment of the patients with metastatic breast cancer remains a major problem. However, there is an intermediate state between the primary tumor and distant metastases called oligome...

Simultaneous Resection of Pancreatic Cancer and Liver Oligometastasis After Induction Chemotherapy

This study is a multi-center phase 3 trial to evaluate a treatment strategy for selecting patients who can benefit from the synchronous resection of primary pancreatic cancer and liver oli...

Stereotactic Body Radiotherapy for Patients With Breast Cancer Oligometastasis

The purpose of this study is to evaluate feasibility to treat metachronous multi-site breast cancer oligometastasis with stereotactic body radiotherapy (SBRT) in patients on systemic thera...

Icotinib as Neoadjuvant and Adjuvant Therapy in EGFR-mutant Stage IIIB or Oligometastasis Non-small Cell Lung Cancer

The main purpose of this study is to evaluate the pulmonary and metastases lesions objective response rate after Icotinib preoperative therapy in EGFR-mutant stage IIIB or oligometastasis ...

Phase II Study of Toripalimab Plus Stereotactic Body Radiotherapy in Colorectal Cancer Patients With Oligometastasis

Metastatic colorectal cancer is one of the common malignant tumors and the overall prognosis is poor. The introduction of immune-checkpoint inhibition (ICI) has led to a paradigm shift in ...

PubMed Articles [3 Associated PubMed Articles listed on BioPortfolio]

Tumor Biology and Multidisciplinary Strategies of Oligometastasis in Gastrointestinal Cancers.

More than 70% of gastrointestinal (GI) cancers are diagnosed with metastases, leading to poor prognosis. For some cancer patients with limited sites of metastatic tumors, the term oligometastatic dise...

Prognostic differences between oligometastatic and polymetastatic extensive disease-small cell lung cancer.

Oligometastasis is a state in which cancer patients have a limited number of metastatic tumors; patients with oligometastases survive longer than those with polymetastases. Extensive disease (ED)-smal...

Stereotactic Ablative Radiotherapy (SAbR) Used to Defer Systemic Therapy in Oligometastatic Renal Cell Cancer.

Stereotactic ablative radiotherapy (SAbR) is a promising alternative for selected renal cell carcinoma (RCC) patients with oligometastasis. The objective of this study was to evaluate the potential of...

Medical and Biotech [MESH] Definitions

None available.

More From BioPortfolio on "Role of Ablative Radiotherapy in the Management of Metastatic Disease: A Prospective Patient Data Registry"

Quick Search

Searches Linking to this Trial